Results: TFBL remarkably reduced LDL C and serum glucose, raised HDL C, improved lipid metabolic disorder and glucose tolerance.

No significant changes in total cholesterol. LDL-C, triglycerides, and vitamin E levels were observed.

观察中总胆固醇，低密度脂蛋白和维生素E的水平没有明显的改变。

NCEP guidelines which classify CVD risk on the basis of LDL-C level, are helpful in targeting individuals at risk early in life.

成人准则分类心血管疾病危险的基础上，LDL-C水平，有利于针对个人在早期生活中的风险。

Elevated serum low-density lipoprotein-cholesterol(LDL-C)is a major risk factor for cardiovascular diseases.

血清低密度脂蛋白-胆固醇（LDL-C）升高是心血管疾病的一个重要危险因素。

Multivariate analysis revealed that the drop in LDL-C and increase in HDL-C both independently predicted atheroma regression.

多变量分析显示LDL-C水平的降低以及HDL-C水平的增加各自都能改善动脉粥样硬化。

However, stating, despite producing marked reductions in LDL-C, are not associated with an increased risk of cancer.

然而，仅管他汀类药物能显著减低低密度脂蛋白，但它与癌症发生率的增高并无内在联系。

Of the patients that had low LDL-C concentrations, normal triglyceride and HDL-C levels, 14 percent had an elevated LDL particle number.

参与研究的病人有低低密度脂蛋白胆固醇水平，正常的甘油三酯和高密度脂蛋白胆固醇水平，有14%的患者低密度脂蛋白粒子数升高。

Probucol did not change serum levl of TG, but the serum levels of TC and LDL-C were significantly lowered.

普罗布考对甘油三酯无明显影响，但是血清总胆固醇及低密度脂蛋白胆固醇均明显降低。

Danshen yin could decrease the level of TC and LDL-c in serum ( P & lt; 0.05 ).

丹参饮亦能降低血清TC、LDL-c的含量 ( P & lt; 0.05 ).

Conclusions: Very low LDL-C and normal SBP are associated with the slowest progression of coronary atherosclerosis.

结论: 非常低水平的LDL -C 和正常SBP与较慢的冠状动脉粥样硬化进展相关.

There was a postive correlation between plasma FFA and hsCRP.

血浆FFA与 hsCRP水平呈正相关;(3)血浆FFA、hsCRP、 TG、 LDL-c 水平与大血管病变呈正相关.

For patients whose LDL C reductions were above the median value.

低密度脂蛋白胆固醇降低高于中间值的病人.

That serum HDL-C was significantly lower but LDL-C has no change in patients with ⅳ type hyperlipemia;

Ⅳ型高脂血症患者HDL-C明显降低，LDL-C无明显变化；

Analysis of tc, tg, HDL-C and LDL-C in elderly diabetes patients with CHD

老年糖尿病合并冠心病患者血浆胆固醇、甘油三酯及高、低密度脂蛋白分析

The concentrations of TG and HDL-C are no difference in all groups ( P0.05).

血清TG和HDL-C浓度在各组无显著差异性（P0.05）。

Results The hemorrheology indexes and the levels of total cholesterol ( TC), triglyceride ( TG), low-density lipoprotein cholesterol ( LDL-C) and very low density lipoprotein cholesterol ( VLDL-C) in ACI group were significantly higher than those in healthy control group ( P0.05 or P0.01).

结果ACI患者血液流变学参数均较健康老年组高（P0.01）；血甘油三酯、总胆固醇、低密度脂蛋白胆固醇、极低密度脂蛋白胆固醇均较健康老年组高（P0.05或P0.01）。

Results Compared to the normal control group, the total cholesterol ( TC) and very low density lipoprotein cholesterol ( vLDL-C) in the CHD group were higher ( p0.01), and the high density lipoprotein cholesterol ( HDL-C) was lower ( P0.01);

结果CHD患者血清中的总胆固醇（TC）和极低密度脂蛋白胆固醇（vLDL-C）均较正常对照组高（P0.01）；高密度脂蛋白胆固醇（HDL-C）较正常对照组低（P0.01）；

Da Huai Mixture was more effective than alcoholic extract of Da Huang in ( 1) reducing TC, VLDL-C, and LDL-C levels and ( 2) stimulating bile acid excretion in rats with experimental hypercholesterolemia.

实验结果表明，大槐合剂降低实验性高胆固醇血症大鼠血清TC、VLDL-C和LDL-C水平以及促进胆汁酸的排泌作用均强于单独应用大黄醇提取物。

Comparison of the indexes of blood lipids: In the treatment group, the triglyceride, cholesterol, LDL-C and VLDL-C after treatment were all decreased as compared with those before treatment, and HDL-C was higher than that before treatment.

血脂各项指标比较：治疗组治疗后的三酰甘油、胆固醇、低密度脂蛋白-胆固醇、极低密度脂蛋白-胆固醇均比治疗前降低，高密度脂蛋白-胆固醇高于治疗前；

EEP and WSP could modulate the metabolize of lipid in DM, decreased the level of TC, TG, LDL-C, VLDL-C and increased the level of HDL-C.

蜂胶能调节糖尿病大鼠体内脂质代谢，降低总胆固醇、甘油三酯、低密度脂蛋白胆固醇、极低密度脂蛋白胆固醇水平，升高高密度脂蛋白胆固醇水平。

Metformin hydrochloride decreased the content of triglyceride, cholesterol and VLDL-C in serums, the content of triglyceride and cholesterol in the liver and the content of cholesterol in Egg.

降低了肝脏中胆固醇和甘油三酯的含量；降低了鸡蛋中胆固醇的含量。